Analyze Diet
The Journal of veterinary medical science2014; 77(1); 75-79; doi: 10.1292/jvms.14-0336

Effects of pre-shipping marbofloxacin administration on fever and blood properties in healthy Thoroughbreds transported a long distance.

Abstract: The present study evaluated the effects of single-dose marbofloxacin in protecting horses against fever associated with transportation using 48 healthy Thoroughbreds. All horses were premedicated with interferon-α (0.5 U/kg, sublingually, every 24 hr) for 2 days before transportation and on the day of transportation. Horses were randomly assigned to receive marbofloxacin (2 mg/kg, IV, once; MRFX group), enrofloxacin (5 mg/kg, IV, once; ERFX group) or saline (0.9% NaCl) solution (10 ml, IV, once; control group) ≤1 hr before being transportation. Each group contained 16 horses (8 males, 8 females). Horses were transported 1,210 km using commercial vans over the course of approximately 26 hr. Clinical examinations and hematologic analyses were performed on all horses both before and after transportation. Post-transportation neutrophil to lymphocyte ratios were significantly lower in horses in the MRFX group compared with the control horses. The serum amyloid A levels were significantly lower in horses in the MRFX group and ERFX group compared with the control horses. Regarding the post-transportation rectal temperatures, fever was detected in 0 horses and 1 horse in the MRFX and ERFX groups, respectively, whereas fevers exceeding 39.1°C were detected in 2 horses in the control group. Additionally, the number of essential post-transportation treatments provided by veterinarians was reduced 3-fold in the MRFX and ERFX groups compared with the saline group. MRFX provided ERFX-like protection against fever associated with long-distance transportation, yielding significantly better protection than saline. Administration of MRFX just before transportation deserves a further study for efficacy in preventing horse fever associated with transportation.
Publication Date: 2014-10-29 PubMed ID: 25720808PubMed Central: PMC4349540DOI: 10.1292/jvms.14-0336Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the effects of administering a single-dose of marbofloxacin to horses before long-distance transportation, finding it significantly reduces the occurrence of post-transportation fever.

Study Design

  • The study included 48 healthy Thoroughbred horses which were all premedicated with interferon-α for two days before the scheduled transport and on the day of transportation.
  • The horses were randomly divided into three groups: marbofloxacin (MRFX group), enrofloxacin (ERFX group), and a saline solution (control group). Each medication was administered intravenously one hour or less before the horses were transported.
  • Each group contained an equal number of males and females (8 each). The horses traveled 1,210 km using commercial vans, a journey that took around 26 hours.
  • Clinical examinations and hematologic analyses were performed on the horses both before and after their journeys.

Outcomes and Findings

  • The ratio of neutrophils to lymphocytes (indicators of inflammation or infection) in the horses’ blood was significantly lower in the MRFX group compared to the control horses after transportation.
  • The serum amyloid A levels (another marker of inflammation) were also significantly lower in the MRFX group and ERFX group compared to the control horses post-transport.
  • Interestingly, none of the horses in the MRFX group experienced a post-transportation fever, and only one horse in the ERFX group had a fever. In contrast, two horses in the control group developed fevers exceeding 39.1°C after the journey.
  • The researchers noted a reduction in the need for post-transportation veterinary treatments in the MRFX and ERFX groups, indicating a positive effect of the medications on the horses’ overall condition.
  • The results showed a similar level of protection against post-transit fever provided by MRFX and ERFX, with both significantly more effective than a saline solution.

Conclusions and Future Directions

  • These findings suggest that administering marbofloxacin just before transporting horses for long distances could effectively prevent fevers associated with such transportation.
  • However, the researchers acknowledge the need for additional studies to further establish the efficiency of marbofloxacin administration in preventing transportation-related horse fever.

Cite This Article

APA
Endo Y, Tsuchiya T, Omura T, Nakai K, Korosue K, Ishimaru M, Ishikawa Y, Hobo S. (2014). Effects of pre-shipping marbofloxacin administration on fever and blood properties in healthy Thoroughbreds transported a long distance. J Vet Med Sci, 77(1), 75-79. https://doi.org/10.1292/jvms.14-0336

Publication

ISSN: 1347-7439
NlmUniqueID: 9105360
Country: Japan
Language: English
Volume: 77
Issue: 1
Pages: 75-79

Researcher Affiliations

Endo, Yoshiro
  • Hidaka Training and Research Center, Japan Racing Association, 535-13 Nishicha, Urakawa-cho, Urakawa-gun, Hokkaido 057-0171 Japan.
Tsuchiya, Takeru
    Omura, Takaya
      Nakai, Kenji
        Korosue, Kenji
          Ishimaru, Mutsuki
            Ishikawa, Yuhiro
              Hobo, Seiji

                MeSH Terms

                • Animals
                • Anti-Bacterial Agents / administration & dosage
                • Anti-Bacterial Agents / therapeutic use
                • Enrofloxacin
                • Female
                • Fever / prevention & control
                • Fever / veterinary
                • Fluoroquinolones / administration & dosage
                • Fluoroquinolones / therapeutic use
                • Horse Diseases / blood
                • Horse Diseases / prevention & control
                • Horses
                • Male
                • Transportation

                References

                This article includes 22 references
                1. Akai M, Hobo S, Wada S. Effect of Low-Dose Human Interferon-alpha on Shipping Fever of Thoroughbred Racehorses.. J Equine Sci 2008;19(4):91-5.
                  doi: 10.1294/jes.19.91pmc: PMC4013948pubmed: 24833959google scholar: lookup
                2. Art T, de Moffarts B, Bedoret D, van Erck E, Lekeux P. Pulmonary function and antimicrobial concentration after marbofloxacin inhalation in horses.. Vet Rec 2007 Sep 8;161(10):348-50.
                  doi: 10.1136/vr.161.10.348pubmed: 17827476google scholar: lookup
                3. Beluche LA, Bertone AL, Anderson DE, Kohn CW, Weisbrode SE. In vitro dose-dependent effects of enrofloxacin on equine articular cartilage.. Am J Vet Res 1999 May;60(5):577-82.
                  pubmed: 10328427
                4. Bermingham EC, Papich MG, Vivrette SL. Pharmacokinetics of enrofloxacin administered intravenously and orally to foals.. Am J Vet Res 2000 Jun;61(6):706-9.
                  doi: 10.2460/ajvr.2000.61.706pubmed: 10850849google scholar: lookup
                5. Bertone AL, Tremaine WH, Macoris DG, Simmons EJ, Ewert KM, Herr LG, Weisbrode SE. Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses.. J Am Vet Med Assoc 2000 Nov 15;217(10):1514-21.
                  doi: 10.2460/javma.2000.217.1514pubmed: 11128543google scholar: lookup
                6. Bousquet-Melou A, Bernard S, Schneider M, Toutain PL. Pharmacokinetics of marbofloxacin in horses.. Equine Vet J 2002 Jul;34(4):366-72.
                  doi: 10.2746/042516402776249191pubmed: 12117108google scholar: lookup
                7. Carretero M, Rodríguez C, San Andrés MI, Forés P, de Lucas JJ, Nieto J, Waxman S, San Andrés MD, González F. Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.. Equine Vet J 2002 Jul;34(4):360-5.
                  doi: 10.2746/042516402776249173pubmed: 12117107google scholar: lookup
                8. Davis E, Rush BR, Herr LG, Ewert KM. Enrofloxacin use in a long-distance transport model of equine respiratory disease.. Vet Ther 2006 Fall;7(3):232-42.
                  pubmed: 17039446
                9. Dechan J. Combination of medical and surgical therapy for pleuropneumonia in a horse.. Can Vet J 1997 Aug;38(8):499-501.
                  pmc: PMC1576807pubmed: 9262860
                10. Giguère S, Sweeney RW, Bélanger M. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.. Am J Vet Res 1996 Jul;57(7):1025-30.
                  pubmed: 8807015
                11. Haines GR, Brown MP, Gronwall RR, Merritt KA. Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.. Can J Vet Res 2000 Jul;64(3):171-7.
                  pmc: PMC1189609pubmed: 10935883
                12. Hobo S, Niwa H, Anzai T. Evaluation of serum amyloid A and surfactant protein D in sera for identification of the clinical condition of horses with bacterial pneumonia.. J Vet Med Sci 2007 Aug;69(8):827-30.
                  doi: 10.1292/jvms.69.827pubmed: 17827889google scholar: lookup
                13. Hobo S, Kuwano A, Oikawa M. Respiratory change in horses during automobile transportation. J. Equine Sci. 1995;6:135–139.
                  doi: 10.1294/jes.6.135google scholar: lookup
                14. Ito S, Hobo S, Eto D, Sato H. Bronchoalveolar lavage for the diagnosis and treatment of pneumonia associated with transport in Thoroughbred racehorses.. J Vet Med Sci 2001 Dec;63(12):1263-9.
                  doi: 10.1292/jvms.63.1263pubmed: 11789602google scholar: lookup
                15. Oikawa M, Kusunose R. Some epidemiologocal aspects of equine respiratory disease associated with transport. J. Equine Sci. 1995;6:25–29.
                  doi: 10.1294/jes.6.25google scholar: lookup
                16. Oikawa M, Takagi S, Anzai R, Yoshikawa H, Yoshikawa T. Pathology of equine respiratory disease occurring in association with transport.. J Comp Pathol 1995 Jul;113(1):29-43.
                17. Orsini JA, Soma LR, Rourke JE, Park M. Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration.. J Vet Pharmacol Ther 1985 Jun;8(2):194-201.
                18. Raidal SL, Love DN, Bailey GD. Effects of posture and accumulated airway secretions on tracheal mucociliary transport in the horse.. Aust Vet J 1996 Feb;73(2):45-9.
                19. Takizawa Y, Hobo S, Yamauchi J, Yamane T, Kuwamoto Y, Wada R, Anzai T. Cytological and bacteriological observation of tracheobronchial aspirates from young Thoroughbred transported by vehicle over long distance. J. Equine Sci. 2005;16:117–121.
                  doi: 10.1294/jes.16.117google scholar: lookup
                20. Tsuchiya T, Hobo S, Endo Y, Narita S, Sakamoto K. Effects of a single dose of enrofloxacin on body temperature and tracheobronchial neutrophil count in healthy Thoroughbreds premedicated with interferon-α and undergoing long-distance transportation.. Am J Vet Res 2012 Jul;73(7):968-72.
                  doi: 10.2460/ajvr.73.7.968pubmed: 22738047google scholar: lookup
                21. Yoon JH, Brooks RL Jr, Khan A, Pan H, Bryan J, Zhang J, Budsberg SC, Mueller PO, Halper J. The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells.. Cell Biol Toxicol 2004 Feb;20(1):41-54.
                22. Yoshikawa H, Yasu T, Ueki H, Oyamada T, Oishi H, Anzai T, Oikawa M, Yoshikawa T. Pneumonia in horses induced by intrapulmonary inoculation of Streptococcus equi subsp. zooepidemicus.. J Vet Med Sci 2003 Jul;65(7):787-92.
                  doi: 10.1292/jvms.65.787pubmed: 12939505google scholar: lookup

                Citations

                This article has been cited 5 times.
                1. Sato W, Sukmawinata E, Uemura R, Kanda T, Kusano K, Kambayashi Y, Sato T, Ishikawa Y, Toya R, Sueyoshi M. Antimicrobial resistance profiles and phylogenetic groups of Escherichia coli isolated from healthy Thoroughbred racehorses in Japan.. J Equine Sci 2020;31(4):85-91.
                  doi: 10.1294/jes.31.85pubmed: 33376444google scholar: lookup
                2. Long A, Nolen-Walston R. Equine Inflammatory Markers in the Twenty-First Century: A Focus on Serum Amyloid A.. Vet Clin North Am Equine Pract 2020 Apr;36(1):147-160.
                  doi: 10.1016/j.cveq.2019.12.005pubmed: 32007299google scholar: lookup
                3. Endo Y, Ishikawa Y, Arima D, Mae N, Iwamoto Y, Korosue K, Tsuzuki N, Hobo S. Effects of pre-shipping enrofloxacin administration on fever and blood properties in adult Thoroughbred racehorses transported a long distance.. J Vet Med Sci 2017 Mar 18;79(3):464-466.
                  doi: 10.1292/jvms.16-0465pubmed: 28111418google scholar: lookup
                4. Endo Y, Hobo S, Korosue K, Ootsuka K, Kitauchi A, Kikkawa R, Hidaka Y, Hagio M, Tsuzuki N. Effects of low-dose G-CSF formulation on hematology in healthy horses after long-distance transportation.. J Vet Med Sci 2015 Apr;77(4):507-9.
                  doi: 10.1292/jvms.14-0586pubmed: 25648988google scholar: lookup
                5. Endo Y, Tsuchiya T, Akiyama K, Takebe N, Nakai K, Korosue K, Ishimaru M, Tsuzuki N, Hobo S. Comparison of the Occurrence of Transportation-associated Fever in 2 Years Old Thoroughbreds before and after Introduction of Prophylactic Marbofloxacin Administration.. J Equine Sci 2014;25(4):79-81.
                  doi: 10.1294/jes.25.79pubmed: 25558181google scholar: lookup